Experts: Mandatory release of patents highly unlikely
The political debate revolving around whether forcibly released patents can push vaccine production forward has no basis in reality, according to pharmaceutical industry legal experts.
BY ANDREAS LØNSTRUP, TRANSLATED BY NIELSINE NIELSEN
The European supply of vaccines will not be increased by forcing pharmaceutical companies to release their patents, and even if this had been the case, the current vaccine production has progressed to a point where notions of mandatory patent releases will be quite outdated and irrelevant in a few months.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
